Andere talen Minerva Neurosciences, Inc.

Aandelen

NERV

US6033802058

Beurs gesloten - Nasdaq Andere beurzen 22:30:00 30-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2,36 ^USD	-2,08%		-6,72%	-61,63%

27/02	Sectorupdate: Aandelen uit de gezondheidszorg dalen aan het eind van de middag	MT
27/02	Top Middag Decliners	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Sector Update: Health Care Stocks Ease Late Afternoon	27/02
Top Midday Decliners	27/02
Sector Update: Health Care Stocks Decline Tuesday Afternoon	27/02
Minerva Neurosciences Shares Tumble After FDA Rejects Roluperidone for Schizophrenia.	27/02
Minerva Neurosciences Shares Slide on Latest FDA Roluperidone Setback	27/02
FDA Turns Away Minerva's Roluperidone Schizophrenia Drug	27/02
Minerva Neurosciences Receives Complete Response Letter from FDA for New Drug Application for Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia	27/02
Minerva Neurosciences Receives Complete Response Letter from FDA for New Drug Application for Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia	27/02
Minerva Neurosciences: Q4 Earnings Snapshot	22/02
Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business Updates	22/02
Minerva Neurosciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	22/02
Minerva Neurosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	22/02
Minerva Neurosciences: Q3 Earnings Snapshot	07/11
Minerva Neurosciences Reports 2023 Third Quarter Financial Results and Business Updates	07/11
Minerva Neurosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	07/11
Minerva Neurosciences : Aug 15, 2023	15-08-23
Minerva Neurosciences: Q2 Earnings Snapshot	01-08-23
Minerva Neurosciences Reports 2023 Second Quarter Financial Results and Business Updates	01-08-23
Minerva Neurosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	01-08-23
Sector Update: Health Care Stocks Declining Late Wednesday	28-06-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Minerva Neurosciences, Inc.

Aandelen

NERV

US6033802058

Andere talen

Filters